Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in pharmaceutical

Pharma and FMCG Stocks Drive Sensex, Nifty

The Sensex and Nifty bounced back higher after closing red in the previous session backed by gains in the Pharma and FMCG counters. The broader markets however outperformed the headline indices as the BSE Midcap registered a fresh record high in the morning deals.

Read More

Glenmark Life Sciences To Invest Rs 600 Cr To Double Capacity In Four Years

Glenmark Life Sciences is into select high value, non-commoditised APIs in chronic therapeutic areas like the cardiovascular, central nervous system, pain management and diabetes, apart from gastro-intestinal disorders, anti-infectives etc.

Read More

Granules Subsidiary Clears USFDA Pre Approval Audit

The FDA issued two minor observations during the audit, the Hyderabad-based drug firm said in a regulatory filing.

Read More

Granules India Concludes COVID-19 Vaccine Drive For All Its Employees In India

The company has also put in place a dedicated 24/7 emergency care helpline, virtual doctor consultations, COVID-care hospital rooms with oxygen support and quarantine centers across Hyderabad and Visakhapatnam, Granules India said.

Read More

Zydus Cadila Gets USFDA Approval For Generic Cancer Drug

The group now has 319 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of the filing process in 2003-04

Read More

Glenmark Pharma Launches COPD Treatment Inhaler In UK

Glenmark's subsidiary Glenmark Pharmaceuticals Europe Ltd had entered into a strategic and exclusive in-licensing arrangement for marketing generic Tiotropium Bromide DPI in Western Europe and the UK in August 2018.

Read More

Zydus Cadila Gets USFDA Tentative Nod For Epilepsy Treatment Drug

The group now has 319 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.

Read More

Glenmark Says Interim Data From Study Supports Favipiravir's Safety, Effectiveness

Glenmark received restricted emergency use approval from India's drug regulator for FabiFlu for the treatment of mild to moderate COVID-19.

Read More

Glenmark Q4 Net Profit Up 6 % At Rs 233.87 Cr

The company's revenue from operations stood at Rs 10,943.9 crore for the fiscal ended March 2021. It was Rs 10,641 crore in 2019-20

Read More

India Reaches Out To US Companies Over Investment In Pharmaceutical, Medical Devices Sector

India, he said, has recently launched a production linked incentive scheme that will provide the US companies new opportunities for investment.

Read More

Glenmark Pharma To Launch Its Nasal Spray Ryaltris In EU

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age.

Read More

Biocon's Arm Gets GMP Compliance Certificate From UK's Health Regulator MHRA For Bengaluru Facility

The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in the week of March 22, 2021

Read More

Clean Science And Technology Files Rs 1,400-Cr IPO Papers

Clean Science Technology manufactures functionally critical specialty chemicals such as performance chemicals, pharmaceutical intermediates and FMCG chemicals.

Read More

“The Big Indian Pli Scheme –Will It Be An Elusive Dream For India’s Tv Manufacturers ?”

India is a very price-sensitive market, its noteworthy to mention that most of the 32inch smart TV that were available for anywhere starting Rs 10,000 onwards are already retailing upwards of Rs 14,000.

Read More

Pfizer COVID-19 Vaccine Reduces Transmission After One Dose - UK Study

Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.

Read More